AI-Designed Drug Makes Patients' Blood Look Biologically Younger, Study Shows — Live Feedhttps://www.live-feeds.com/feed/ai-designed-drug-makes-patients-blood-look-biologically-younger-study-showsContinuously updated, source-cited coverage. AI-Designed Drug Makes Patients' Blood Look Biologically Youngerhttps://www.live-feeds.com/feed/ai-designed-drug-makes-patients-blood-look-biologically-younger-study-showshttps://www.live-feeds.com/feed/ai-designed-drug-makes-patients-blood-look-biologically-younger-study-shows#u67608Mon, 14 Sep 2026 07:45:17 +0000An artificial intelligence-generated drug initially developed for lung disease has shown early clinical data indicating it can slow biological aging. Evaluated in a phase 2a clinical trial incorporating proteomic aging clocks, the medication achieved a surprising bonus effect by making patients' blood appear biologically younger. Insilico's co-chief executive officer has expressed big hopes that the fibrosis treatment might offer a chance to stop biological aging and even reverse it, according to early findings from the study.Why it mattersThe integration of proteomic aging clocks in